These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Borrelia burgdorferi, clinical aspects, cultivation and identification of the pathogen in erythema migrans in Berlin]. Ott A; Schönberg A Z Hautkr; 1989 Aug; 64(8):644-8. PubMed ID: 2678789 [TBL] [Abstract][Full Text] [Related]
3. Has the presence or absence of Borrelia burgdorferi sensu lato as detected by skin culture any influence on the course of erythema migrans? Logar M; Lotric-Furlan S; Maraspin V; Cimperman J; Jurca T; Ruzić-Sabljić E; Strle F Wien Klin Wochenschr; 1999 Dec; 111(22-23):945-50. PubMed ID: 10666806 [TBL] [Abstract][Full Text] [Related]
4. Sensitivity of culture and polymerase chain reaction for the etiologic diagnosis of erythema migrans. Zore A; Ruzić-Sabljić E; Maraspin V; Cimperman J; Lotric-Furlan S; Pikelj A; Jurca T; Logar M; Strle F Wien Klin Wochenschr; 2002 Jul; 114(13-14):606-9. PubMed ID: 12422609 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of immunofluorescence test (IFT) and immuno (western) blot (WB) test in patients with erythema migrans. Ruzić-Sabljić E; Maraspin V; Cimperman J; Lotric-Furlan S; Strle F Wien Klin Wochenschr; 2002 Jul; 114(13-14):586-90. PubMed ID: 12422606 [TBL] [Abstract][Full Text] [Related]
6. [Borrelia strains that cause erythema migrans in Alsace, France]. Antoni-Bach N; Jaulhac B; Hansmann Y; Limbach F; Lipsker D Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):15-8. PubMed ID: 11937923 [TBL] [Abstract][Full Text] [Related]
7. Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three borrelia species. Stanek G; Breier F; Menzinger G; Schaar B; Hafner M; Partsch H Wien Klin Wochenschr; 1999 Dec; 111(22-23):951-6. PubMed ID: 10666807 [TBL] [Abstract][Full Text] [Related]
8. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification. Lebech AM APMIS Suppl; 2002; (105):1-40. PubMed ID: 11985118 [TBL] [Abstract][Full Text] [Related]
9. Electron microscopy of Langerhans cells and Borrelia burgdorferi in Lyme disease patients. Hulínská D; Barták P; Hercogová J; Hancil J; Basta J; Schramlová J Zentralbl Bakteriol; 1994 Jan; 280(3):348-59. PubMed ID: 8167429 [TBL] [Abstract][Full Text] [Related]
10. [Erythema migrans with multiple lesions]. Constantin C; Peter O; Cerottini J; Derighetti M; Panizzon R; Guggisberg D Ann Dermatol Venereol; 2000 May; 127(5):513-6. PubMed ID: 10863185 [TBL] [Abstract][Full Text] [Related]
11. Isolation of Borrelia burgdorferi sensu lato from a fibrous nodule in a patient with acrodermatitis chronica atrophicans. Maraspin V; Ruzić-Sabljić E; Strle F Wien Klin Wochenschr; 2002 Jul; 114(13-14):533-4. PubMed ID: 12422596 [TBL] [Abstract][Full Text] [Related]
12. [Cutaneous B cell lymphoma in chronic Borrelia burgdorferi infection. Report of 2 cases and a review of the literature]. Garbe C; Stein H; Gollnick H; Taud W; Orfanos CE Hautarzt; 1988 Nov; 39(11):717-26. PubMed ID: 3072322 [TBL] [Abstract][Full Text] [Related]
13. Atypical Lyme borreliosis in an HIV-infected man. Cordoliani F; Vignon-Pennamen MD; Assous MV; Vabres P; Dronne P; Rybojad M; Morel P Br J Dermatol; 1997 Sep; 137(3):437-9. PubMed ID: 9349345 [TBL] [Abstract][Full Text] [Related]
14. [In vivo and in vitro detection of borrelia infection in morphea-like skin changes with negative Borrelia serology]. Schempp C; Bocklage H; Owsianowski M; Lange R; Orfanos CE; Gollnick H Hautarzt; 1993 Jan; 44(1):14-8. PubMed ID: 8436502 [TBL] [Abstract][Full Text] [Related]
15. Antibody responses to borrelia IR(6) peptide variants and the C6 peptide in Swedish patients with erythema migrans. Tjernberg I; Sillanpää H; Seppälä I; Eliasson I; Forsberg P; Lahdenne P Int J Med Microbiol; 2009 Aug; 299(6):439-46. PubMed ID: 19138558 [TBL] [Abstract][Full Text] [Related]
16. [Morphea--a tick transmitted borreliosis of the skin? A contribution to the pathogenesis of circumscript scleroderma]. Büchner SA Z Hautkr; 1989 Aug; 64(8):661-4, 667-9. PubMed ID: 2678791 [TBL] [Abstract][Full Text] [Related]
17. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea. Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918 [TBL] [Abstract][Full Text] [Related]
18. Association of specific subtypes of Borrelia burgdorferi with hematogenous dissemination in early Lyme disease. Wormser GP; Liveris D; Nowakowski J; Nadelman RB; Cavaliere LF; McKenna D; Holmgren D; Schwartz I J Infect Dis; 1999 Sep; 180(3):720-5. PubMed ID: 10438360 [TBL] [Abstract][Full Text] [Related]
19. No detection of Borrelia burgdorferi-specific DNA in erythema migrans lesions after minocycline treatment. Muellegger RR; Zoechling N; Soyer HP; Hoedl S; Wienecke R; Volkenandt M; Kerl H Arch Dermatol; 1995 Jun; 131(6):678-82. PubMed ID: 7778919 [TBL] [Abstract][Full Text] [Related]
20. [Borrelial erythema of the face]. de Heller-Milev M; Peter O; Panizzon RG; Laffitte E Ann Dermatol Venereol; 2008 Dec; 135(12):852-4. PubMed ID: 19084697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]